Effect of Phosphodiesterase-5 (PDE-5) Inhibitors on Clinical Outcomes in Patients With Pulmonary Hypertension: A Meta-Analysis of Randomized Control Trials

We intended to summarize the most recent research pertaining to the use of phosphodiesterase-5 (PDE5) inhibitors in pulmonary hypertension in light of recent developments in the knowledge of the pathophysiological mechanisms and treatments for pulmonary hypertension, with major contributions in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Karedath, Jithin, Dar, Hassaan, Ganipineni, Vijay Durga Pradeep, Gorle, Sri Anjali, Gaddipati, Sarvani, Bseiso, Anan, Pizzorno, Guiomarly, Shaik, Tanveer Ahamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiac/Thoracic/Vascular Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897597/
https://www.ncbi.nlm.nih.gov/pubmed/36751241
http://dx.doi.org/10.7759/cureus.33363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897597/
https://www.ncbi.nlm.nih.gov/pubmed/36751241
http://dx.doi.org/10.7759/cureus.33363

Ejemplares similares